Correlation Between ProQR Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both ProQR Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProQR Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProQR Therapeutics BV and Eliem Therapeutics, you can compare the effects of market volatilities on ProQR Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProQR Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProQR Therapeutics and Eliem Therapeutics.
Diversification Opportunities for ProQR Therapeutics and Eliem Therapeutics
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ProQR and Eliem is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding ProQR Therapeutics BV and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and ProQR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProQR Therapeutics BV are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of ProQR Therapeutics i.e., ProQR Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between ProQR Therapeutics and Eliem Therapeutics
Given the investment horizon of 90 days ProQR Therapeutics BV is expected to generate 1.1 times more return on investment than Eliem Therapeutics. However, ProQR Therapeutics is 1.1 times more volatile than Eliem Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 290.00 in ProQR Therapeutics BV on August 27, 2024 and sell it today you would earn a total of 72.00 from holding ProQR Therapeutics BV or generate 24.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.78% |
| Values | Daily Returns |
ProQR Therapeutics BV vs. Eliem Therapeutics
Performance |
| Timeline |
| ProQR Therapeutics |
| Eliem Therapeutics |
ProQR Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ProQR Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite ProQR Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProQR Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| ProQR Therapeutics vs. Eliem Therapeutics | ProQR Therapeutics vs. HCW Biologics | ProQR Therapeutics vs. Scpharmaceuticals | ProQR Therapeutics vs. Milestone Pharmaceuticals |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance |